Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2014
Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysisDavid S Kotlyar, James D Lewis, Laurent Beaugerie, et al.Gastroenterologia Y Hepatologia|July 5, 2011
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experienceJosé Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 14, 2020
Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort studyAna Garcia Garcia de Paredes, Enrique Rodriguez de Santiago, Carlos Rodriguez-Escaja, et al.Journal of Crohn'S & Colitis|March 24, 2017
Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel DiseaseCarlos Taxonera, Ángel Ponferrada, Fernando Bermejo, et al.Journal of Gastroenterology|October 11, 2016
Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patientsMarisa Iborra, Javier Pérez-Gisbert, Marta Maia Bosca-Watts, et al.Journal of Crohn'S & Colitis|July 28, 2018
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel DiseaseCarlos Taxonera, Ángel Ponferrada, Sabino Riestra, et al.Inflammatory Bowel Diseases|March 3, 2016
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort StudyIván Guerra, Tamara Pérez-Jeldres, Marisa Iborra, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2022
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registryMíriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, et al.Alimentary Pharmacology & Therapeutics|May 3, 2025
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCUMaría José Casanova, Cristina Rubín de Célix, Sabino Riestra, et al.Alimentary Pharmacology & Therapeutics|October 4, 2018
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registryMaría Chaparro, Ana Garre, Elena Ricart, et al.Pageof 4